Skip to main content

ADVERTISEMENT

supportive care

News
06/19/2020
Researchers from the University of Arizona Cancer Center conducted simulation modeling of cost savings from conversion of pegfilgrastim to biosimilar pegfilgrastim-cbqv for the prophylaxis of chemotherapy-induced...
Researchers from the University of Arizona Cancer Center conducted simulation modeling of cost savings from conversion of pegfilgrastim to biosimilar pegfilgrastim-cbqv for the prophylaxis of chemotherapy-induced...
...
06/19/2020
Journal of Clinical Pathways
Research Reports
12/17/2019
Ashley E Glode, PharmD, BCOP
S Lindsey Davis, MD
Supriya K Jain, MD
Megan D Marsh, PA
Lisa J Wingrove, RD
Tracey E Schefter, MD
Karyn Goodman, MD, MS
Lindel CK Dewberry, MD
Martin D McCarter, MD
Laura Melton, PhD
Michelle Bunch, CSW
Abstract: A standard treatment recommendation for esophageal cancer patients with stage IB-IIIB disease is for neoadjuvant chemoradiation followed by surgery. This trimodality therapy can be difficult for patients to...
Abstract: A standard treatment recommendation for esophageal cancer patients with stage IB-IIIB disease is for neoadjuvant chemoradiation followed by surgery. This trimodality therapy can be difficult for patients to...
...
12/17/2019
Journal of Clinical Pathways